A breakthrough in "undruggable" proteins: Gleipnir Lífsmiðja is a biotechnology company that opens new doors in drug development with revolutionary technology that finds solutions against the 80% disease-causing proteins that have so far been considered undruggable.
BioForge
KLAK health is a five-week business accelerator tailored to the needs of health technology startups, ranging from digital health technology solutions to medical technology, biotechnology, and pharmaceutical development.
KLAK health's sponsors are Landspítali, the Ministry of Health, Íslandsbanki, Helix, Securitas, Heilsuvernd, Lifa VC, Össur, Nox Medical, Frumtök and Lyfja.







